The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to GSK5764227 (GSK’227) for the treatment of adult patients with relapsed or refractory (R/R) osteosarcoma who have ...

The OraQuick HIV Self-Test is an in-vitro diagnostic home-use antibody test that utilizes oral fluid to determine whether a patient has been exposed to HIV.

Zinplava ™ (bezlotoxumab) injection will be discontinued as of January 31, 2025, according to the Food and Drug Administration’s (FDA) drug shortages tracker.

HealthDay News — Gestational exposure to nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with an increased risk for childhood chronic kidney disease (CHD), although the association is not ...

While vaccination is the best way to protect against whooping cough, vaccination rates in children have fallen ...

Clinical practice guideline also presents recommendations for specialist care and primary care of patients with Alzheimer disease, dementia.

HealthDay News — Among privately insured US adolescents who identified as transgender and gender-diverse (TGD), receipt of puberty blockers and hormones was rare from 2018 to 2022, according to a ...

An expert panel consisting of dietitians, doctors, nutritional epidemiologists, chefs, and weight loss researchers examined ...

Budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol ...

The Company is also studying P1101 in the single-arm phase 2B EXCEED-ET trial (ClinicalTrials.gov Identifier: NCT05482971) to evaluate the efficacy, safety, and tolerability of P1101 in adult patients ...

The NDA is supported by data from the open-label, single-center phase 1/2 90-CH-0149 trial and the open-label, single-arm phase 3 09-CH-0059 study.

Odds of complications significantly reduced with early anti-TNFα therapy, especially in those with perianal lesions ...